One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Elevating the Patient Voice in Metastatic Hormone-Sensitive Prostate Cancer Clinical Trials.
Dzimitrowicz, Hannah E. MD 1,; Armstrong, Andrew J. MD, ScM 1,,
doi : 10.1200/JCO.21.02504
Volume 40(8) pgs. 807-919 March 10, 2022
Beyond Survival: The US Food and Drug Administration Confirms Surrogate End Points for Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Intensive Chemotherapy.
DiNardo, Courtney D. MD 1,,; Pollyea, Daniel A. MD 2,
doi : 10.1200/JCO.21.02762
Interpreting ORATOR: Lessons Learned From a Randomized Comparison of Primary Surgical and Radiation Approaches for Early-Stage Oropharyngeal Cancer.
Mowery, Yvonne M. MD, PhD 1,2,; Salama, Joseph K. MD 1,3,,
doi : 10.1200/JCO.21.02813
Isn't Androgen Deprivation Enough? Optimal Treatment for Newly Diagnosed Metastatic Prostate Cancer.
Morgans, Alicia K. MD, MPH 1,,; Beltran, Himisha MD 1,
doi : 10.1200/JCO.21.02530
Quality of Life in Men With Prostate Cancer Randomly Allocated to Receive Docetaxel or Abiraterone in the STAMPEDE Trial.
Rush, Hannah L. MBChB 1; Murphy, Laura PhD 1; Morgans, Alicia K. MD 2,; Clarke, Noel W. ChM 3,; Cook, Adrian D. MSc 1; Attard, Gerhardt MD, PhD 4,; Macnair, Archie MBBS 1,5; Dearnaley, David P. MD 6,; Parker, Christopher C. MD 6,; Russell, J. Martin MBChB 7; Gillessen, Silke MD 8,; Matheson, David PhD 9; Millman, Robin 1; Brawley, Christopher D. MSc 1,; Pugh, Cheryl BSc 1; Tanguay, Jacob S. MBChB 10,; Jones, Robert J. PhD 7,; Wagstaff, John MD 11,; Rudman, Sarah PhD 5,; O'Sullivan, Joe M. MD 12,; Gale, Joanna BM, DM 13; Birtle, Alison MD 14,15,; Protheroe, Andrew PhD 16,; Gray, Emma MBChB 17,; Perna, Carla MD 18; Tolan, Shaun MBBCh 19; McPhail, Neil MBChB 20,; Malik, Zaf I. MBChB 19,; Vengalil, Salil MBBS 21,; Fackrell, David MBChB 22; Hoskin, Peter MD 15,23,; Sydes, Matthew R. MSc 1,; Chowdhury, Simon MD, PhD 5,; Gilbert, Duncan C. PhD 1; Parmar, Mahesh K. B. DPhil 1,; James, Nicholas D. PhD 6,; Langley, Ruth E. PhD 1,,
doi : 10.1200/JCO.21.00728
Health-Related Quality of Life in Metastatic, Hormone-Sensitive Prostate Cancer: ENZAMET (ANZUP 1304), an International, Randomized Phase III Trial Led by ANZUP.
Stockler, Martin R. MBBS, MSc 1,,; Martin, Andrew J. MBBS, PhD 1; Davis, Ian D. PhD 2,; Dhillon, Haryana M. BSc, MA, PhD 3,; Begbie, Stephen D. MBBS 4,; Chi, Kim N. MD 5,; Chowdhury, Simon MBBS, PhD 6,; Coskinas, Xanthi BHSc, MMedSc (Clin Epid) 1; Frydenberg, Mark MBBS 2,; Hague, Wendy E. MBBS, MBA, PhD, GAICD 1; Horvath, Lisa G. MBBS, PhD 7,; Joshua, Anthony M. BSc, MBBS, PhD 8,; Lawrence, Nicola J. MBChB, PhD 9; Marx, Gavin M. BSc (Med), MBBS 10,; McCaffrey, John MBBCh, BAO 11; McDermott, Ray MD, PhD 12,; McJannett, Margaret RN 13; North, Scott A. MD 14,; Parnis, Francis MBBS 15,; Parulekar, Wendy R. MD 16; Pook, David W. MBBS, MD 17; Reaume, M. Neil BSc, MD, MSc 18,; Sandhu, Shahneen MBBS 19,; Tan, Alvin MBChB 20; Tan, Thean Hsiang MBBS 21,; Thomson, Alastair BM 22,; Vera-Badillo, Francisco MD, MSc 23,; Williams, Scott G. MBBS, MD 19,; Winter, Diana G. BSc 1; Yip, Sonia BSc, PhD 1; Zhang, Alison Y. MBBS, MMed 1,; Zielinski, Robert R. MBBS 24,; Sweeney, Christopher J. MBBS 25,; for the ENZAMET Trial Investigators and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)
doi : 10.1200/JCO.21.00941
Response Rate, Event-Free Survival, and Overall Survival in Newly Diagnosed Acute Myeloid Leukemia: US Food and Drug Administration Trial-Level and Patient-Level Analyses.
Norsworthy, Kelly J. MD 1,; Gao, Xin PhD 1; Ko, Chia-Wen PhD 1; Pulte, E. Dianne MD 1; Zhou, Jiaxi MS 1; Gong, Yutao PhD 1,; Shen, Yuan Li PhD 1; Vallejo, Jonathon PhD 1,; Gwise, Thomas E. PhD 1; Sridhara, Rajeshwari PhD 2; Deisseroth, Albert B. MD, PhD 1; Farrell, Ann T. MD 1; de Claro, R. Angelo MD 1; Blumenthal, Gideon M. MD 2,; Pazdur, Richard MD 2
doi : 10.1200/JCO.21.01548
Measurable Residual Disease Response and Prognosis in Treatment-Naive Acute Myeloid Leukemia With Venetoclax and Azacitidine.
Pratz, Keith W. MD 1,,; Jonas, Brian A. MD 2,; Pullarkat, Vinod MD 3,; Recher, Christian MD 4,; Schuh, Andre C. MD 5,; Thirman, Michael J. MD 6,; Garcia, Jacqueline S. MD 7,; DiNardo, Courtney D. MD 8,; Vorobyev, Vladimir MD 9,; Fracchiolla, Nicola S. MD 10,; Yeh, Su-Peng MD 11,; Jang, Jun Ho MD 12,; Ozcan, Muhit MD 13,; Yamamoto, Kazuhito MD 14,; Illes, Arpad MD 15,; Zhou, Ying PhD 16,; Dail, Monique PhD 17,; Chyla, Brenda PhD 16,; Potluri, Jalaja MD 16,; Dohner, Hartmut MD 18,
doi : 10.1200/JCO.21.01546
Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR Trial.
Nichols, Anthony C. MD 1,,; Theurer, Julie PhD 2; Prisman, Eitan MD 3; Read, Nancy MD 4; Berthelet, Eric MD 5,; Tran, Eric MD 5; Fung, Kevin MD 1; de Almeida, John R. MD, MSc 6; Bayley, Andrew MD 7; Goldstein, David P. MD 6; Hier, Michael MD 8; Sultanem, Khalil MD 9; Richardson, Keith MD 8; Mlynarek, Alex MD 8; Krishnan, Suren MD 10; Le, Hien MD 11; Yoo, John MD 1; MacNeil, S. Danielle MD, MSc 1; Winquist, Eric MD, MSc 12,; Hammond, J. Alex MBBCh 4; Venkatesan, Varagur MBBS 4; Kuruvilla, Sara MD 12; Warner, Andrew MSc 4; Mitchell, Sylvia MRT 4; Chen, Jeff PhD 4; Corsten, Martin MD 13; Johnson-Obaseki, Stephanie MD, MPH 13; Odell, Michael MD 13; Parker, Christina AuD 14; Wehrli, Bret MD 15; Kwan, Keith MD 15; Palma, David A. MD, PhD 4,
doi : 10.1200/JCO.21.01961
Blood-Based Biomarker Panel for Personalized Lung Cancer Risk Assessment.
Fahrmann, Johannes F. PhD 1,; Marsh, Tracey PhD 2; Irajizad, Ehsan PhD 1,3; Patel, Nikul MS 1,; Murage, Eunice PhD 1; Vykoukal, Jody PhD 1; Dennison, Jennifer B. PhD 1,; Do, Kim-Anh PhD 3; Ostrin, Edwin MD, PhD 4,; Spitz, Margaret R. MPH 5; Lam, Stephen MD 6,; Shete, Sanjay PhD 7,; Meza, Rafael PhD 8; Tammemagi, Martin C. PhD 9,10,; Feng, Ziding PhD 2,; Hanash, Samir M. MD, PhD 1,,
doi : 10.1200/JCO.21.01460
Risk of Adverse Financial Events in Patients With Cancer: Evidence From a Novel Linkage Between Cancer Registry and Credit Records.
Shankaran, Veena MD, MS 1,2,,; Li, Li MS 1; Fedorenko, Catherine MS 1; Sanchez, Hayley MSc 1; Du, Yuxian PhD 3,; Khor, Sara MS 4; Kreizenbeck, Karma BA 1; Ramsey, Scott MD, PhD 1,
doi : 10.1200/JCO.21.01636
Adjuvant Therapy for Stage II Colon Cancer: ASCO Guideline Update.
Baxter, Nancy N. MD, PhD 1; Kennedy, Erin B. MHSc 2; Bergsland, Emily MD 3,; Berlin, Jordan MD 4,; George, Thomas J. MD 5,; Gill, Sharlene MD, MPH, MBA 6,; Gold, Philip J. MD 7; Hantel, Alex MD 8; Jones, Lee MBA 9,; Lieu, Christopher MD 10,; Mahmoud, Najjia MD 11,; Morris, Arden M. MD, MPH 12; Ruiz-Garcia, Erika MD, MS 13,; You, Y. Nancy MD, MHSc 14; Meyerhardt, Jeffrey A. MD, MPH 15,
doi : 10.1200/JCO.21.02538
Navigating Difficult Waters: A Cancer Journey.
Omlin, Aurelius G. MD 1,,; Nestor, Karen MD 1,
doi : 10.1200/JCO.21.01838
Physical Activity Patterns and Cognitive Function in Patients With Breast Cancer.
Ning, Shipeng MD; Qiao, Kun MD; Pan, Linghui MD
doi : 10.1200/JCO.21.02073
Reply to S. Ning et al.
Salerno, Elizabeth A. PhD, MPH; Culakova, Eva PhD; Heckler, Charles E. PhD; Janelsins, Michelle C. PhD, MPH
doi : 10.1200/JCO.21.02600
